Reliability of the oral glucose tolerance test in the early postoperative assessment of acromegaly remission

Journal of Neurosurgery

Volumn 97, Issue 6, 2002, Pages 1282-1286

  Kristof, Rudolf A ^a,b   Neuloh, Georg ^a   Redel, Lioba ^a   Klingmüller, Dietrich ^a   Schramm, Johannes ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Acromegaly; Growth hormone; Insulin like growth factor; Oral glucose tolerance test; Pituitary adenoma; Transsphenoidal surgery

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADJUVANT THERAPY; ADULT; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS FUNCTION; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL GLUCOSE TOLERANCE TEST; OUTCOMES RESEARCH; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RELIABILITY; REMISSION; TRANSSPHENOIDAL SURGERY;

EID: 0036896064     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2002.97.6.1282     Document Type: Article

References (15)

1. Buchfelder M, Brockmeier S, Fahlbusch R, et al: Recurrence following transsphenoidal surgery for acromegaly. Horm Res 35:113-118, 1991
2. Chen HS, Lin HD: Serum and IGFBP-3 levels for the assessment of disease activity of acromegaly. J Endocrinol Invest 22:98-103, 1999
3. Dobrashian RD, O'Halloran DJ, Hunt A, et al: Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly. Clin Endocrinol 38:589-593, 1993
4. Giustina A, Barkan A, Casanueva FF, et al: Criteria for cure of acromegaly: A consensus statement. J Clin Endocrinol Metab 85:526-529, 2000
5. Graham KE, Samuels MH, Raff H, et al: Intraoperative adrenocorticotropin levels during transsphenoidal surgery for Cushing's disease do not predict cure. J Clin Endocrinol Metab 82:1776-1779, 1997
6. Hattori N, Shimatsu A, Kato Y, et al: Growth hormone responses to oral glucose loading measured by highly sensitive enzyme immunoassay in normal subjects and patients with glucose intolerance and acromegaly. J Clin Endocrinol Metab 70:771-776, 1990
7. Kayath MJ, Russo EMK, Dib SA, et al: Do impaired glucose tolerance and diabetes mellitus interfere with the interpretation of the growth hormone response to the oral glucose tolerance test? Braz J Med Biol Res 25:449-455, 1992
8. Laws ER, Vance ML, Thapar K: Pituitary surgery for the management of acromegaly. Horm Res 53 (Suppl 3):71-75, 2000
9. Losa M, Oeckler R, Schopohl J, et al: Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly. J Neurosurg 70:561-567, 1989
10. Losa M, Schopohl J, Stalla GK, et al: Growth hormone releasing factor-test in acromegaly: Comparison with other dynamic tests. Clin Endocrinol 23:99-109, 1985
11. Owens D, Srivastava MC, Tompkins CV, et al: Studies on the metabolic clearance rate, apparent distribution space and plasma half-disappearance time of unlabelled human growth hormone in normal subjects and in patients with liver disease, renal disease, thyroid disease and diabetes mellitus. Eur J Clin Invest 3:284-294, 1973
12. Parfitt VJ, Flanagan D, Wood P, et al: Outpatient assessment of residual growth hormone secretion in treated acromegaly with overnight urinary growth hormone excretion, random serum growth hormone and insulin like growth factor-1. Clin Endocrinol 49:647-652, 1998
13. Peacey S, Shalet SM: Insulin-like growth factor 1 measurement in diagnosis and management of acromegaly. Ann Clin Biochem 38:297-303, 2001
14. Stoffel-Wagner B, Springer W, Bidlingmaier F, et al: A comparison of different methods for diagnosing acromegaly. Clin Endocrinol 46:531-537, 1997
15. Thorner MO, Vance ML, Laws ER Jr, et al: The anterior pituitary, in Wilson JD, Foster DW, Kronenberg HM, et al (eds): Williams Textbook of Endocrinology, Ed 9. Philadelphia: WB Saunders, 1998, pp 249-340